Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
World J Gastroenterol. 2013 Jan 7;19(1):86-91. doi: 10.3748/wjg.v19.i1.86.
To investigate the short and long-term outcomes of endoscopic balloon dilatation (EBD) for Crohn's disease (CD) strictures.
Between January 1995 and December 2011, 47 EBD procedures were performed in 30 patients (8 females and 22 males) with CD. All patients had strictures through which an endoscope could not pass, and symptoms of these strictures included abdominal pain, abdominal fullness, nausea, and/or vomiting. The 47 strictures included 17 anastomotic and 30 de novo strictures. Endoscopy and dilatation were performed under conscious sedation with intravenous diazepam or flunitrazepam. The dilatations were all performed using through-the-scope balloons with diameters from 8 mm to 20 mm on inflation and lengths of 30-80 mm. Each dilatation session consisted of two to four, 3-min multistep inflations of the balloon, repeated at intervals of 1 wk until adequate dilatation (up to 15-20 mm in diameter) was achieved. The follow-up data were collected from medical records and analyzed retrospectively. Primary success was defined as passage of the scope through the stricture after EBD. Long-term outcomes were analyzed focusing on intervention-free survival and surgery-free survival demonstrated by the Kaplan-Meier method. (Intervention-free meant cases in which neither endoscopic balloon re-dilatation nor surgery was needed after the first dilatation during the observation period). The log rank test was used to evaluate the difference in long-term outcomes between anastomotic and de novo stricture cases.
Primary success was achieved in 44 of the 47 strictures (93.6%). Balloon dilatations failed in 3 cases (6.4%). In 1 case, EBD was a technical failure because the guide-wire could not be passed through the stricture which showed severe adhesion and was a flexural lesion of the intestine. In 2 cases, unexpected perforations occurred immediately after balloon dilatation. Of the 47 treatments, complications occurred in 5 (10.6%). All 5 patients had de novo strictures. One suffered bleeding, two high fever and there were colorectal perforations. One of the patients with a colorectal perforation was treated surgically, the other was managed conservatively. These 2 cases correspond to the two aforementioned EBD failures. Long-term outcomes were evaluated for the 44 successfully-treated strictures after a median follow-up of 26 mo (range, 2-172 mo). During the observation period, re-strictures after EBDs occurred in 26 cases (60.5%). Fourteen of these 26 re-stricture cases underwent EBD again, but in two EBD failed and surgery was ultimately performed in both cases. Twelve of the 26 re-stricture cases were initially treated surgically when the re-strictures occurred. Finally, 30 of the 47 strictures (63.8%) were successfully managed with EBD, allowing surgery to be avoided. Intervention-free survival evaluated by the Kaplan-Meier method was 75% at 12 mo, 58% at 24 mo, and 43% at 36 mo. There was no significant difference between the anastomotic strictures (n = 16) and de novo strictures (n = 28) in the intervention-free survival as evaluated by the log-rank test. Surgery-free survival evaluated by the Kaplan-Meier method was 90% at 12 mo, 75% at 24 mo, and 53% at 36 mo. The 16 anastomotic strictures were associated with significantly better surgery-free survivals than the 28 de novo strictures (log-rank test: P < 0.05).
Anastomotic strictures were associated with better long-term outcomes than de novo strictures, indicating that stricture type might be useful for predicting the long-term outcomes of EBD.
探讨内镜下球囊扩张(EBD)治疗克罗恩病(CD)狭窄的短期和长期疗效。
1995 年 1 月至 2011 年 12 月,对 30 例(8 例女性,22 例男性)CD 狭窄患者进行了 47 次 EBD 治疗。所有患者均有内镜无法通过的狭窄,且这些狭窄的症状包括腹痛、腹胀、恶心和/或呕吐。47 条狭窄中有 17 条吻合口狭窄和 30 条新发狭窄。在静脉注射地西泮或氟硝西泮镇静下进行内镜和扩张,使用直径 8 至 20 毫米、长 30 至 80 毫米的经内镜球囊进行扩张。每次扩张包括 2 至 4 次、每次 3 分钟的多步充气,每 1 周重复 1 次,直至达到充分扩张(直径达 15-20 毫米)。从病历中收集随访数据并进行回顾性分析。主要成功定义为 EBD 后内镜通过狭窄。采用 Kaplan-Meier 法分析无干预生存和无手术生存的长期结果。(无干预是指在观察期内首次扩张后既不需要内镜球囊再扩张也不需要手术)。对数秩检验用于评估吻合口狭窄和新发狭窄病例的长期结果差异。
47 条狭窄中有 44 条(93.6%)达到主要成功。3 例(6.4%)球囊扩张失败。1 例为技术失败,原因是导丝无法通过狭窄处,狭窄处显示严重粘连,且为肠弯曲病变。2 例在球囊扩张后立即出现意外穿孔。47 次治疗中,有 5 例(10.6%)发生并发症。所有 5 例均为新发狭窄。1 例出现出血,2 例出现高热,有 2 例发生结直肠穿孔。其中 1 例结直肠穿孔患者接受了手术治疗,另 1 例接受了保守治疗。这 2 例对应于上述 2 例 EBD 失败病例。对中位随访 26 个月(范围 2-172 个月)的 44 例成功治疗的狭窄进行了长期结果评估。在观察期间,EBD 后再次发生狭窄 26 例(60.5%)。其中 14 例再次接受 EBD 治疗,但有 2 例 EBD 失败,最终均进行了手术。26 例再狭窄中有 12 例在再狭窄发生时最初接受了手术治疗。最终,30 例(63.8%)狭窄通过 EBD 成功治疗,避免了手术。Kaplan-Meier 法评估的无干预生存在 12 个月时为 75%,在 24 个月时为 58%,在 36 个月时为 43%。吻合口狭窄(n = 16)和新发狭窄(n = 28)的无干预生存无显著差异,对数秩检验(log-rank test)。Kaplan-Meier 法评估的无手术生存在 12 个月时为 90%,在 24 个月时为 75%,在 36 个月时为 53%。16 例吻合口狭窄与 28 例新发狭窄相比,无手术生存显著更好(对数秩检验:P < 0.05)。
吻合口狭窄的长期疗效优于新发狭窄,表明狭窄类型可能有助于预测 EBD 的长期疗效。